Clinical Trials for EpicentRx

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: EpicentRx

Clinical Trials (3)

NCT05966194
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
PHASE2Recruiting
216 participants
Started: Apr 2, 2024 · Completed: Oct 1, 2025
1 condition1 sponsor14 locations
NCT05566041
A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer
PHASE3Active, not recruiting
292 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
PHASE2Recruiting
140 participants
Started: Mar 29, 2021 · Completed: Mar 1, 2027
6 conditions1 sponsor6 locations